Weighted prevalence of chronic symptoms
| Total sample (n=5191) | Women (n=2737) | Men (n=2454) | p Value* | |
|---|---|---|---|---|
| Joint pain | 47.7% (45.7% to 49.7%) | 51.5% (48.6% to 54.3%) | 42.5% (39.9% to 45.1%) | <0.001 |
| Back pain | 34.7% (32.8% to 36.5%) | 38.2% (35.4% to 40.9%) | 29.8% (27.4% to 32.2%) | <0.001 |
| Stomach/intestine problems | 22.1% (20.5% to 23.8%) | 26.3% (23.8% to 28.9%) | 16.4% (14.4% to 18.3%) | <0.001 |
| Mental impairments | 18.3% (16.7% to 19.9%) | 19.0% (16.8% to 21.3%) | 17.3% (15.3% to 19.3%) | 0.288 |
| Urinary incontinence | 17.4% (15.8% to 19.0%) | 21.4% (19.0% to 23.8%) | 11.9% (10.2% to 13.7%) | <0.001 |
| Impaired sexual life | 16.9% (15.6% to 18.1%) | 4.5% (3.4% to 5.6%) | 33.9% (31.4% to 36.3%) | <0.001 |
| Dyspnoea | 16.9% (15.4% to 18.5%) | 18.4% (16.2% to 20.7%) | 14.9% (13.0% to 16.8%) | 0.022 |
| Swollen legs | 13.4% (12.0% to 14.7%) | 14.8% (12.8% to 16.9%) | 11.3% (9.6% to 13.0%) | 0.010 |
| Dizziness/vertigo | 10.3% (9.0% to 11.6%) | 12.2% (10.2% to 14.1%) | 7.7% (6.3% to 9.1%) | <0.001 |
| Skin problems | 9.8% (8.6% to 11.0%) | 9.3% (7.6% to 11.0%) | 10.5% (8.9% to 12.2%) | 0.285 |
| Persistent cough | 4.6% (3.8% to 5.4%) | 5.0% (3.8% to 6.1%) | 4.1% (3.0% to 5.1%) | 0.285 |
| Chest pain | 3.1% (2.3% to 3.8%) | 3.3% (2.2% to 4.4%) | 2.7% (1.9% to 3.6%) | 0.459 |
| Number of chronic symptoms | ||||
| 0 | 17.1% (15.7% to 18.6%) | 15.9% (13.9% to 17.8%) | 18.9% (16.8% to 21.0%) | 0.002 |
| 1 | 24.9% (23.2% to 26.6%) | 24.1% (21.7% to 26.5%) | 26.0% (23.7% to 28.3%) | |
| 2 | 22.0% (20.3% to 23.6%) | 21.9% (19.5% to 24.2%) | 22.1% (19.9% to 24.4%) | |
| 3 | 16.8% (15.3% to 18.4%) | 17.6% (15.4% to 19.8%) | 15.8% (13.8% to 17.7%) | |
| 4 | 9.3% (8.2% to 10.5%) | 9.8% (8.1% to 11.5%) | 8.7% (7.2% to 10.2%) | |
| ≥5 | 9.8% (8.6% to 11.1%) | 10.8% (8.9% to 12.7%) | 8.5% (7.0% to 10.0%) | |
Data are weighted prevalence (95% CIs).
*Logistic regression.